Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.12% | 34.59% | 2.74% | -73.29% | -0.20% |
| Total Depreciation and Amortization | 2.13% | 196.79% | -2.75% | -76.90% | 0.20% |
| Total Amortization of Deferred Charges | -2.14% | -196.24% | -2.71% | 169.44% | -0.21% |
| Total Other Non-Cash Items | 2.12% | -26.19% | -2.77% | 660.90% | -0.25% |
| Change in Net Operating Assets | -2.09% | -- | -- | -- | -0.22% |
| Cash from Operations | -2.12% | 30.76% | 2.75% | 1.38% | -0.21% |
| Capital Expenditure | -2.18% | -112.21% | 2.88% | -457.14% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.67% | 45.26% | 2.84% | -984.62% | 0.00% |
| Cash from Investing | -2.09% | -63.18% | 2.65% | -555.07% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 25.85% | 0.00% | -91.30% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.12% | 1,715.61% | 2.71% | -104.94% | 0.21% |
| Foreign Exchange rate Adjustments | -2.17% | -273.97% | -2.79% | 8,085.71% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.12% | 169.17% | 2.74% | -211.84% | 0.21% |